These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 562569)

  • 21. Increased activity of antithymus serum after absorption with splenic lymphocytes.
    Lueker DC; Tribble JL
    Nature; 1969 Feb; 221(5181):682-5. PubMed ID: 5774948
    [No Abstract]   [Full Text] [Related]  

  • 22. In vivo antibody production by spleen cells after incubation in vitro with heterologous antilymphocyte plasma.
    Jeejeebhoy HF; Rabbat AG
    Nature; 1968 Dec; 220(5174):1350-2. PubMed ID: 4882918
    [No Abstract]   [Full Text] [Related]  

  • 23. Passive enhancement of rat heart allografts by xenogeneic antidonor sera raised in rabbits.
    Horikawa S; Monden M; Mori T; Okamura J; Kosaki G
    Transplantation; 1982 Feb; 33(2):138-42. PubMed ID: 6460361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The immunosuppressive effect of antilymphocyte sera produced by sensitization with different lymphoid tissues.
    Sterling WA; Elveback LR; Shorter RG
    Transplantation; 1970 Oct; 10(4):297-301. PubMed ID: 4927385
    [No Abstract]   [Full Text] [Related]  

  • 25. Stimulation of DNA synthesis in the culture of mouse spleen cells by means of heterologous antilymphocytic and antiglobulin sera.
    Skamene E; Sejkorová J; Nouza K; Iványi J
    Folia Biol (Praha); 1968; 14(4):289-92. PubMed ID: 4176052
    [No Abstract]   [Full Text] [Related]  

  • 26. Serum-derived immunosuppressive substances. II. An evaluation of various sources for an endogenous regulator of lymphocyte activation.
    Miller F; Habicht GS
    Int Arch Allergy Appl Immunol; 1977; 55(1-6):228-38. PubMed ID: 22495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cytologic shifts in the blood and spleen in immunized rats after the administration of antilymphocytic, antinuclear or antithymus serum].
    Kartasheva AL; Isachenkov VA; Polushkina EF; Kashkin KP
    Tsitologiia; 1970 Sep; 12(9):1156-63. PubMed ID: 5534544
    [No Abstract]   [Full Text] [Related]  

  • 28. [The immunodepressive and lympholytic action of kortifen].
    Pykhtina AA; Gladkova NE
    Farmakol Toksikol; 1988; 51(5):72-4. PubMed ID: 3208888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytology and histology of haemopoietic cell transplantation under the influence of antilymphocyte serum (ALS) in mice. I. The in vivo effect of antilymphocytic globulin on haemopoietic tissue.
    Rodriguez-Paradisi E; Thierfelder S; Götze D; Eulitz M; Beil E
    Clin Exp Immunol; 1971 Jan; 8(1):107-19. PubMed ID: 4993197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of antilymphocyte sera on antibody forming cells and macrophages in the early immune response.
    Barth RF; Hunter RL; Southworth J
    Transplant Proc; 1969 Mar; 1(1):433-5. PubMed ID: 4944255
    [No Abstract]   [Full Text] [Related]  

  • 31. [Isolation from a pregnant woman of a serum protein responsible for inhibiting an in vitro cytotoxicity reaction].
    Piquet Y; Fizet D; Bousquet J; Platel D; Cabantous F; Dubecq JP; Moulinier J
    C R Seances Soc Biol Fil; 1983; 177(2):175-82. PubMed ID: 6224538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A population of lymphocytes bearing a membrane receptor antigen-antibody-complement complexes. II. Specific isolation.
    Eden A; Bianco C; Nussenzweig V
    Cell Immunol; 1971 Dec; 2(6):658-69. PubMed ID: 5317411
    [No Abstract]   [Full Text] [Related]  

  • 33. [From the search for a lymphocytic chalone to the rediscovery of serum thymic factor (FTS)].
    Lenfant M; Millerioux L; Duchange N; Tanzer J
    C R Seances Acad Sci III; 1981 Feb; 292(5):403-5. PubMed ID: 6452968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytotoxic immune cells with specificity for defined soluble antigens. 3. Separation from helper cells and from antibody-forming cell precursors.
    Schirrmacher V; Rubin B; Golstein P; Wigzell H; Andersson B
    Transplant Proc; 1973 Dec; 5(4):1447-50. PubMed ID: 4544162
    [No Abstract]   [Full Text] [Related]  

  • 35. Mechanism of specific suppression of delayed hypersensitivity response by anti-lymphocyte serum.
    Nene SP; Sainis KB; Phondke GP
    Immunol Lett; 1982 Apr; 4(4):185-8. PubMed ID: 6178685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Methods of obtaining antilymphocytic and antimacrophage sera].
    Dzheksenbaev OSh
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Mar; (3):20-3. PubMed ID: 86251
    [No Abstract]   [Full Text] [Related]  

  • 37. The immunosuppressive properties of sub-fractions of antilymphocytic IgG of equine origin.
    James K; Pullar DM; Brydon J
    Immunology; 1971 Aug; 21(2):247-57. PubMed ID: 5571539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppressor cell activity in tumor-bearing mice. III. Co-purification of a factor inhibiting cellular DNA synthesis and DNA polymerase activity.
    Farrar WL; Elgert KD; Foo AS
    J Immunol; 1981 Dec; 127(6):2339-44. PubMed ID: 6457873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Separation of mouse spleen cells by passage through columns of sephadex G-10.
    Ly IA; Mishell RI
    J Immunol Methods; 1974 Aug; 5(3):239-47. PubMed ID: 4610054
    [No Abstract]   [Full Text] [Related]  

  • 40. Separation of lymphocyte mitogen from lymphotoxin and experiments on the production of lymphotoxin by lymphoid cells stimulated with the partially purified mitogen: a possible amplification mechanism of cellular immunity and allergy.
    Gately CL; Gately MM; Mayer MM
    J Immunol; 1976 Mar; 116(3):669-75. PubMed ID: 1082890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.